Caregiver Outlook: An Intervention to Improve Caregiving in Serious Illness
NCT ID: NCT01672294
Last Updated: 2017-04-17
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
286 participants
INTERVENTIONAL
2013-06-30
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will examine whether a preparation and completion intervention reduces caregiver anxiety, depression, anticipatory grief, and burden and improves patient quality of life and health care use.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outlook Quality of Life Intervention
NCT00784095
Phase I/II Cancer Caregiver Interventions to Improve Quality of Life and Prevent Burnout
NCT02166866
Older Cancer Caregiver Needs Post Hospital Discharge
NCT02099526
Cancer Caregiver Burden: Targeting Emotion Regulation in a Trial
NCT02322905
Improvement of Information to Cancer Patients' Caregivers
NCT02380469
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Caregivers in the first group ("Treatment", or "Preparation and life completion") will meet with a facilitator three times for a period of forty-five minutes each. In the first session, subjects will be asked to discuss issues related to relationship life review.
In session two, participants will be asked to speak in more depth about issues such as regret and forgiveness. In the final session, subjects will focus on legacy and celebration. Caregivers in the second group ("attention control" or "relaxation meditation") will meet with a facilitator three times for a period of forty-five minutes each and be asked to listen to a non-guided relaxation compact disk (CD) or participate in a guided relaxation exercise.
Participants in both groups will receive pre and post-test measures administered by a blinded interviewer. Outcome measures will be measures by the Functional Assessment of Cancer Therapy - General (FACT-G), Quality of life scale, FACIT-sp sub-scale, Anticipatory Grief Scale, Caregiver Reaction Assessment, the Qual-E completion and preparation sub-scales, and patient days at home.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
treatment
three facilitator-led end-of-life preparation and completion sessions with a facilitator with both patient and caregiver
Preparation and life completion
Caregiver subjects will discuss life review, issues of forgiveness and heritage and legacy.
attention control
three facilitator led sessions of listening to a relaxation CD.
Attention Control
Caregiver subjects will listen to a non-guided relaxation CD with facilitator.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Preparation and life completion
Caregiver subjects will discuss life review, issues of forgiveness and heritage and legacy.
Attention Control
Caregiver subjects will listen to a non-guided relaxation CD with facilitator.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Caregiver with Cognitive impairment/inability to speak on phone/non-English speaking
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karen E Steinhauser, PhD
Role: PRINCIPAL_INVESTIGATOR
Durham VA Medical Center, Durham, NC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Durham VA Medical Center, Durham, NC
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IIR 11-347
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.